Concourse Financial Group Securities’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Concourse Financial Group Securities’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-400	Closed	-$9.64K	–	2485
2023 Q1	$9.64K	Hold	400	–	–	﹤0.01%	1674
2022 Q4	$4.23K	Hold	400	–	–	﹤0.01%	1894
2022 Q3	$2K	Hold	400	–	–	﹤0.01%	1835
2022 Q2	$2K	Hold	400	–	–	﹤0.01%	2069
2022 Q1	$3K	Buy	+400	New	+$2.39K	﹤0.01%	1987

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Concourse Financial Group Securities's PRVB Position: Q2 2023 in Review

Concourse Financial Group Securities sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 400 shares — an estimated $9.64K sold.

Concourse Financial Group Securities first reported a position in PRVB in Q1 2022 and held it in 5 quarters. The position peaked at $9.64K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Concourse Financial Group Securities reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Concourse Financial Group Securities sold 400 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $9.64K.
Concourse Financial Group Securities first reported a position in Provention Bio, Inc. Common Stock in Q1 2022 and held it in 5 quarters.
Concourse Financial Group Securities's Provention Bio, Inc. Common Stock position peaked at $9.64K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Concourse Financial Group Securities's 13F filing for Q2 2023, filed 10 Aug 2023.